These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Indications for the therapeutic use of contraceptive steroids]. Nocke W Med Welt; 1975 Aug; 6(35):1509-17. PubMed ID: 1100993 [TBL] [Abstract][Full Text] [Related]
24. [Therapeutic and contraceptive use of oral progestogens]. Zontag FE Sov Med; 1968 Jun; 31(6):45-53. PubMed ID: 4907193 [No Abstract] [Full Text] [Related]
25. [Results of clinical trials of ovostat as a contraceptive and therapeutic agent]. Shturkalev I; Katsulov A Akush Ginekol (Sofiia); 1970; 9(5):383-7. PubMed ID: 5526636 [No Abstract] [Full Text] [Related]
26. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives]. Ebeling K; Kühndel K; Rothe K Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517 [No Abstract] [Full Text] [Related]
27. [The "sequential" method with a new estrogen-progesterone combination in ovulation control]. Bailo U; Finzi C Minerva Ginecol; 1968 Dec; 20(23):1885-7. PubMed ID: 5734793 [No Abstract] [Full Text] [Related]
29. [Biochemical-hormonal bases for the selection of contraceptives for oral use]. Cortés-Gallegos V Gac Med Mex; 1980 Jul; 116(7):323-6. PubMed ID: 7429083 [No Abstract] [Full Text] [Related]
30. [Ovariostatic drugs and their use in gynecologic pathology]. Vaglio N Arch Ostet Ginecol; 1967; 72(6):693-706. PubMed ID: 4237146 [No Abstract] [Full Text] [Related]
31. A new progestogen-estrogen combination for gynecologic therapy and contraception. Linthorst G Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282 [No Abstract] [Full Text] [Related]
32. Our experience with sequential estrogen-progestin treatments to inhibit ovulation. Cittadini E; Quartararo P; Romano F Int J Fertil; 1969; 14(2):180-7. PubMed ID: 4181574 [No Abstract] [Full Text] [Related]
33. Observations with anteovin "step-up" contraceptive tablet in young women. Takács G; Hámori M Ther Hung; 1986; 34(3):150-4. PubMed ID: 3441877 [No Abstract] [Full Text] [Related]
34. Experience with infecundin tablets. Szontágh F Ther Hung; 1968; 16(1):11-9. PubMed ID: 5651016 [No Abstract] [Full Text] [Related]
35. [Drug therapy of menstruation related complaints]. Juvkam KH; Gudim HB Tidsskr Nor Laegeforen; 2011 May; 131(9-10):956-8. PubMed ID: 21606994 [No Abstract] [Full Text] [Related]
38. [Anemias in young women. The internist's viewpoint]. Rousso C Schweiz Rundsch Med Prax; 1980 Nov; 69(47):1731-3. PubMed ID: 7255329 [No Abstract] [Full Text] [Related]
39. [On vicarious menstruation, in relation to a successfully treated unusual case]. Tokin R Akush Ginekol (Sofiia); 1966; 5(2):140-2. PubMed ID: 6001380 [No Abstract] [Full Text] [Related]
40. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Shargil AA Int J Fertil; 1985; 30(1):15, 18-28. PubMed ID: 2862116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]